<DOC>
	<DOCNO>NCT02451566</DOCNO>
	<brief_summary>The primary objective LIFE Study demonstrate clinical cost benefit associate use Ovation Prime Abdominal Stent Graft System least invasive condition define Fast-Track EVAR protocol . The key element Fast-Track EVAR protocol include : appropriate patient selection , bilateral percutaneous access , general anesthesia , ICU admission post procedure , next day discharge .</brief_summary>
	<brief_title>TriVascular Canadian LIFE Study : Least Invasive Fast-Track EVAR ( Endovascular Aneurysm Repair )</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm , Abdominal</mesh_term>
	<criteria>1 . Patient ≥ 18 year age . 2 . Patients male nonpregnant female ( female child bear potential must negative pregnancy test prior enrollment study ) . 3 . Patient sign Research Ethics Board ( REB ) approve Informed Consent Form . 4 . Patient consider treat physician candidate elective open surgical repair AAA ( i.e. , category I , II , III per American Society Anesthesiology ( ASA ) classification ; refer Appendix III : ASA Classification System ) . 5 . Patient infrarenal abdominal aortic aneurysm meet least one following : Abdominal aortic aneurysm &gt; 5cm diameter Aneurysm increase size 0.5cm last 6 month Maximum diameter aneurysm exceed 1.5 time transverse dimension adjacent nonaneurysmal aortic segment 6 . Patient suitable anatomy allow use TriVascular Ovation/Ovation Prime Abdominal Stent Graft System : Iliac femoral artery allow endovascular access TriVascular Ovation/Ovation Prime Abdominal Stent Graft System ( 14F OD ) . Proximal aortic neck land zone inner wall diameter le 16 mm great 30 mm 13 mm inferior renal artery . Proximal aortic neck length least 7 mm proximal aneurysm Distal iliac artery land zone inner wall diameter le 8 mm great 20 mm . Distal iliac artery land zone inner wall diameter le 8 mm great 20 mm . Distance distal renal artery superior internal iliac artery measurement least 130 mm . 7 . Patient suitable femoral artery percutaneous access site allow use Perclose ProGlide SutureMediated Closure ( SMC ) System via preclose technique , include : ≥5 mm diameter At least 2 cm segment access , 10 mm origin profunda femoris branch 10 mm low margin inferior epigastric artery determine preoperative contrastenhanced CT , angiography , ultrasound . No calcification anterior wall circumferential ( &gt; 50 % ) calcification posterior wall . No prior groin incision , hematoma , significant scarring . No prior clip collagen base vascular closure device placement within 90 day procedure . No prior femoral artery needle puncture within 30 day procedure . No current active localize groin infection , traumatic vascular injury , femoral artery aneurysm , arteriovenous ( AV ( fistula , pseudoaneurysm . 8 . Patient must willing comply require followup exam . 1 . Patient need emergent surgery . 2 . Patient dissect aneurysm . 3 . Patient acutely rupture aneurysm . 4 . Patient acute vascular injury . 5 . Patient previous repair abdominal aortic aneurysm iliac artery . 6 . Patient mycotic aneurysm active systemic infection . 7 . Patient unstable angina ( define angina progressive increase symptom , new onset rest nocturnal angina , onset prolonged angina ) . 8 . Patient unstable peripheral artery disease critical limb ischemia ( CLI ) . 9 . Patient congestive heart failure ( CHF ) . Subjects Class I II allow participate protocol , subject Class III IV exclude . The New York Heart Association NYHA Functional Classification use reference , see Appendix III . 10 . Patient myocardial infarction ( MI ) and/or stroke ( CVA ) within past 3 month . 11 . Patient require use technique ( e.g . Chimney graft ) would cover renal artery . 12 . Patient require plan adjunctive device ( e.g . renal stent ) complete procedure . 13 . Patient major surgical interventional procedure plan within ± 30 day AAA repair . 14 . Patient history connective tissue disease ( e.g. , Marfan 's Ehler'sDanlos syndrome ) . 15 . Patient history bleed disorder refuse blood transfusion . 16 . Patient dialysis dependent renal failure baseline serum creatinine level &gt; 2.0mg/dl . 17 . Patient known hypersensitivity contraindication anticoagulation contrast medium amenable pretreatment . 18 . Patient know allergy intolerance polytetrafluoroethylene ( PTFE ) , PEG base polymer , fluorinated ethylene propylene ( FEP ) nitinol . 19 . Patient home oxygen . 20 . Patient morbidly obese ( BMI ≥ 40 kg/m2 ) . 21 . Patient admit skilled nursing facility . 22 . Patient limited life expectancy le 1 year . 23 . Patient inability discharge within 1 day ( one midnight stay ) procedure . Examples include limited , comorbid condition , unable admit day procedure , live far away treatment center , insufficient postoperative family support . 24 . Patient currently participate investigational device drug clinical trial . 25 . Patient medical social psychological condition , opinion investigator , preclude receive pretreatment , require treatment , posttreatment procedure evaluation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Abdominal</keyword>
	<keyword>Aortic</keyword>
	<keyword>Aneurysm</keyword>
</DOC>